Multimodal visualization agents designed to enhance image-guided high-precision cancer therapy including surgery, radiotherapy, and chemotherapy
小明加速器2025-outline
Learn how Nanovista’s proprietary technology illuminate tumors both at the planning stage and inside the operating room.
小明加速器2025-outline
- Sector: Oncology/Image-guided interventions
- ip加速器破解 Multimodal imaging agent for cancer surgery and image-guided intervention
- Market Size: $2.7 Billion by 2025
- Development Stage: Pre-IND
小明加速器2025-outline
Nanovista Team
Email: info@nanovista.com